Because of an aging population and rapid development of new medications, dentistry
and medicine will likely face a significant increase in patients with drug related
reactions.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Atlas of the Oral and Maxillofacial Surgery Clinics of North AmericaAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- An aging nation: the older population in the United States, current population reports, P25–1140.U.S. Census Bureau, Washington, DC2014 (Available at:)
- Management of angiotensin-converting enzyme inhibitor-induced angioedema.Laryngoscope. 2011; 121: 2327-2334
- Oral and maxillofacial pathology.4th edition. Elsevier, St Louis (MO)2015
- Allergic dermatoses.Prim Care Clin Off Pract. 2016; 43: 433-449
- NSAID-induced urticaria and angioedema: a reappraisal of its clinical management.Am J Clin Dermatol. 2002; 3: 599-607
- Angioedema.J Am Acad Dermatol. 2005; 53: 373-388
- Determinants of angiotensin-converting enzyme inhibitor (ACEI) intolerance and angioedema in the UK clinical practice research datalink.Br J Clin Pharmacol. 2016; 82: 1647-1659
- Hereditary angioedema.N Engl J Med. 2008; 359: 1027-1036
- Pharmacologic management of angioedema induced by angiotensin-converting enzyme inhibitors.Am J Health Syst Pharm. 2016; 73: 873-879
- Treatment of ACEI-related angioedema with icatibant: a case series.Intern Emerg Med. 2015; 10: 345-350
- Oral erythema multiforme: trends and clinical findings of a large retrospective European case series.Oral Surg Oral Med Oral Pathol Oral Radiol. 2015; 120: 707-716
- Drug induced erythema multiforme: two case series with review of literature.J Clin Diagn Res. 2014; 8: ZH01-ZH04
- Drug induced oral erythema multiforme: a rare and less recognized variant of erythema multiforme.J Oral Maxillofac Pathol. 2012; 16: 145-148
- Clinical features, diagnosis, and treatment of erythema multiforme: a review for the practicing dermatologist.Int J Dermatol. 2012; 51: 889-902
- Recurrent erythema multiforme: clinical characteristics, etiologic associations, and treatment in a series of 48 patients at Mayo Clinic, 2000 to 2007.J Am Acad Dermatol. 2010; 62: 45-53
- Imatinib mesylate-induced erythema multiforme: recurrence after rechallenge with 200 mg/day imatinib.Ann Dermatol. 2015; 27: 641-643
- Case series of three infants with erythema multiforme following hepatitis B vaccination.Pediatr Neonatal. 2016; 57: 72-75
- Erythema multiforme: a review of epidemiology, pathogenesis, clinical features, and treatment.Dent Clin North Am. 2013; 57: 583-596
- Adverse drug reactions in the orofacial region.Crit Rev Oral Biol Med. 2004; 15: 221-239
- Association between calcium channel blockers and gingival hyperplasia.J Clin Periodontol. 2010; 37: 625-630
- Amlodipine induced gingival hyperplasia: a rare entity.Int J Cardiol. 2007; 122: e23-e24
- Another adverse effect of vemurafenib: gingival hyperplasia.J Dermatol. 2016; 43: 706-707
- Vemurafenib-associated gingival hyperplasia in patient with metastatic melanoma.J Am Acad Dermatol. 2014; 71: e205-e206
- Management of cyclosporine and nifedipine-induced gingival hyperplasia.J Clin Diagn Res. 2015; 9: ZD12-ZD15
- Drug-associated gingival enlargement.J Periodontol. 2004; 75: 1424-1431
- Comparison of azithromycin and oral hygiene program in the treatment of cyclosporine-induced gingival hyperplasia.Ren Fail. 2007; 29: 265-270
- Roxithromycin reduces cyclosporine-induced gingival hyperplasia in renal transplant patients.Transplant Proc. 2008; 40: 1435-1438
- Pulmonary adverse events of anti-tumor necrosis factor-alpha antibody therapy.Am J Med. 2006; 119: 639-646
- Biological insights from clinical trials with anti-TNF therapy.Springer Semin Immunopathol. 1998; 20: 211-228
- Evaluating equality in psoriasis healthcare: a cohort study of the impact of age on prescription of biologics.Br J Dermatol. 2016; 174: 579-587
- Efficiency of biological therapies in patients with moderate to severe psoriasis: impact of a pharmacotherapeutic protocol.J Dermatolog Treat. 2016; 27: 198-202
- Do biologic-treated psoriatic arthritis patients with spondylitis respond differently with or without concomitant methotrexate from patients without spondylitis?.J Rheumatol. 2016; 43: 471-473
- Emerging adverse cutaneous drug reactions.Dermatol Clin. 2012; 30 (vii): 695-730
- Dermatological conditions during TNF-alpha-blocking therapy in patients with rheumatoid arthritis: a prospective study.Arthritis Res Ther. 2005; 7: R666-R676
- The long-term effect of anti TNF-alpha treatment on temporomandibular joints, oral mucosa, and salivary flow in patients with active rheumatoid arthritis: a pilot study.Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005; 100: 433-440
- Does anti-tumour necrosis factor-alpha increase oral candida colonization? A case–control study in psoriatic patients.Acta Derm Venereol. 2013; 93: 352-353
- Pneumocystis carinii pneumonia with oral candidiasis after infliximab therapy for Crohn's disease.Dig Dis Sci. 2004; 49: 1458-1460
- Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.JAMA. 2006; 295: 2275-2285
- Does cancer that occurs during or after anti-tumor necrosis factor therapy have a worse prognosis? A national assessment of overall and site-specific cancer survival in rheumatoid arthritis patients treated with biologic agents.Arthritis Rheum. 2011; 63: 1812-1822
- Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis.Ann Rheum Dis. 2011; 70: 1895-1904
- Cautionary note: a possible association between oral squamous cell carcinoma and tumor necrosis factor antagonists; need for oral screening.J Clin Rheumatol. 2010; 16: 197-199
- Oropharyngeal carcinoma arising after methotrexate and etanercept therapy for rheumatoid arthritis.Oral Surg Oral Med Oral Pathol Oral Radiol. 2014; 117: e261-e263
- Severe oral epithelial dysplasia in a patient receiving adalimumab therapy.J Oral Pathol Med. 2005; 34: 447-448
- Autoimmune bullous skin diseases occurring under anti-tumor necrosis factor therapy: two case reports.Dermatology. 2010; 221: 201-205
- Lichenoid reaction induced by adalimumab.J Eur Acad Dermatol Venereol. 2008; 22: 626-627
Article info
Footnotes
Disclosures: No relationship with a commercial company.
Identification
Copyright
© 2017 Elsevier Inc. All rights reserved.
